Enteric fever, commonly known as typhoid fever, presents a significant global health challenge, particularly in low-resource settings. Early diagnosis and effective management are crucial to reduce morbidity and mortality. This article provides an integrated approach to the diagnosis and management of enteric fever.
Diagnosis of enteric fever is primarily based on clinical suspicion, backed up by microbiological confirmation. Blood culture remains the gold standard, despite its limitations in sensitivity. Molecular methods like PCR have shown promise, but are not widely available in resource-limited settings. Serological tests, despite their lower sensitivity and specificity, are often used due to their cost-effectiveness and ease of use.
The mainstay of treatment for enteric fever is antimicrobial therapy. Choice of antimicrobial should be guided by local susceptibility patterns. Fluoroquinolones, third-generation cephalosporins, and azithromycin are commonly used. Resistance to these agents is a growing concern, necessitating regular antimicrobial susceptibility testing. Adjunctive care, including hydration and symptom management, is also important.
Prevention of enteric fever relies on improving sanitation and access to clean water. Vaccination can also play a role, particularly in endemic areas. The WHO recommends the typhoid conjugate vaccine for children over six months in endemic areas. However, vaccination should not replace efforts to improve water, sanitation, and hygiene.
Enteric fever remains a significant health burden, particularly in resource-limited settings. An integrated approach to diagnosis and management, incorporating clinical suspicion, microbiological confirmation, effective antimicrobial therapy, and preventive measures, can significantly reduce this burden. As healthcare professionals, we have a pivotal role in implementing these strategies and advocating for improved access to clean water and sanitation.
1.
New Nanoparticles Can Destroy Undruggable Cancer Proteins
2.
Brain MRI Surveillance Alone Helps Preserve Cognition in Small Cell Lung Cancer
3.
NEET SS Counseling 2023: MCC provides information on DNB SS Medical Oncology seats available at ESIC Medical College and Hospital Faridabad.
4.
Belzutifan Plus Pembro Approved for Adjuvant RCC
5.
Using MRD Status to Deescalate Multiple Myeloma Therapy
1.
Diagnosis and Treatment of Follicular Thyroid Cancer: A Comprehensive Guide
2.
Obesity as a major risk factor for cancer
3.
Unraveling the Genetic Mystery of Hereditary Spherocytosis
4.
Advanced Pathways in Oncology for Better Care
5.
Essential Updates in Hematology in Daily Practice
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
3.
Understanding Anemia and Its Common Causes
4.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
5.
Early Cancer Detection Saves Lives
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation